← Open Payments lookup

RACHEL KOZOL: Open Payments

NPI 1164567749 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$202 in 10 payments from 6 companies in 2025. Trend: 2023 $69 · 2024 $118 · 2025 $202

Food & beverage: $202
CompanyPaymentsAmount
Alkermes, Inc.4$73
ABBVIE INC.2$39
Janssen Pharmaceuticals, Inc1$36
Teva Pharmaceuticals USA, Inc.1$21
E.R. Squibb & Sons, L.L.C.1$17
Otsuka America Pharmaceutical, Inc.1$17

Products named: ARISTADA, VRAYLAR, INVEGA SUSTENNA, UZEDY, COBENFY, ABILIFY MAINTENA, VIVITROL.

Industry payments across NE — which companies pay providers there.